[1]朱虹颖,嵇再雄,王建波.血管外膜在血管成形术后再狭窄中的作用[J].介入放射学杂志,2023,32(03):293-297.
　ZHU Hongying,JI Zaixiong,WANG Jianbo..The role of adventitia in the formation of restenosis after angioplasty[J].journal interventional radiology,2023,32(03):293-297.

点击复制

血管外膜在血管成形术后再狭窄中的作用()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Indolfi C，Iaconetti C，Gareri C，et al. Non- coding RNAs in vascular remodeling and restenosis［J］. Vascul Pharmacol， 2019， 114： 49- 63.
［2］ Ren H，Zhuang J，Li X，et al. Avoiding revascularization strategy versus revascularization with drug- coated balloon for the treatment of superficial femoral artery occlusive disease［J］. J Interv Med， 2021， 4： 87- 93.
［3］ Yan J，Wang WB，Fan YJ，et al. Cyclic stretch induces vascular smooth muscle cells to secrete connective tissue growth factor and promote endothelial progenitor cell differentiation and angiogenesis［J］. Front Cell Dev Biol， 2020， 8： 606989.
［4］ 郑 辉，郭富强． Rho/Rho激酶信号通路与支架内再狭窄的研究［J］． 介入放射学杂志， 2012， 21：172- 175．
［5］ Sbierski- Kind J，Mroz N，Molofsky AB. Perivascular stromal cells： directors of tissue immune niches［J］. Immunol Rev， 2021， 302： 10- 31.
［6］ Li XD， Hong MN， Chen J， et al. Adventitial fibroblast- derived vascular endothelial growth factor promotes vasa vasorum- associated neointima formation and macrophage recruitment［J］. Cardiovasc Res， 2020， 116： 708- 720.
［7］ Tesfamariam B. Periadventitial local drug delivery to target restenosis［J］. Vascul Pharmacol， 2017： S1537- 1891（17）30235.
［8］ Sartore S，Chiavegato A，Faggin E，et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling： from innocent bystander to active participant［J］. Circ Res， 2001， 89： 1111- 1121.
［9］ 何 钰，王建波，王 武． 颅内动脉粥样硬化性狭窄支架植入术后再狭窄机制及治疗新进展［J］． 介入放射学杂志， 2021， 30：1184- 1189．
［10］ 钟继明，黄学成，张景昌，等． 冠状动脉雷帕霉素涂层支架植入术后支架内再狭窄临床预测因素探讨［J］． 介入放射学杂志， 2017， 26：874- 877．
［11］ Coen M，Gabbiani G，Bochaton- Piallat ML. Myofibroblast- mediated adventitial remodeling： an underestimated player in arterial pathology［J］. Arterioscler Thromb Vasc Biol， 2011， 31： 2391- 2396.
［12］ Welten SM，Goossens EA，Quax PH，et al. The multifactorial Nature of microRNAs in vascular remodelling［J］. Cardiovasc Res， 2016， 110： 6- 22.
［13］ Wang L， Wu T， Si C， et al. Danlou tablet activates autophagy of vascular adventitial fibroblasts through PI3K/Akt/mTOR to protect cells from damage caused by atherosclerosis［J］. Front Pharmacol， 2021， 12： 730525.
［14］ Chen Y，Chen Y，Jiang X，et al. Vascular adventitial fibroblasts- derived FGF10 promotes vascular smooth muscle cells proliferation and migration in vitro and the neointima formation in vivo［J］. J Inflamm Res， 2021， 14： 2207- 2223.
［15］ Yu B，Liu Z，Fu Y，et al. CYLD deubiquitinates nicotinamide adenine dinucleotide phosphate oxidase 4 contributing to adventitial remodeling［J］. Arterioscler Thromb Vasc Biol， 2017， 37： 1698- 1709.
［16］ 李 彤，赵明镜，韩小婉，等． 血管外膜成纤维细胞在动脉粥样硬化及PCI后再狭窄中的作用［J］． 中西医结合心脑血管病杂志，2018， 16：49- 53．
［17］ 徐 芳，刘 颖，齐 洁，等． 阿托伐他汀对ApoE基因敲除小鼠血管外膜成纤维细胞表型的影响［J］． 中国病理生理杂志， 2016， 32：1599- 1607．
［18］ Kennon AM， Stewart JA Jr. RAGE differentially altered in vitro responses in vascular smooth muscle cells and adventitial fibroblasts in diabetes- induced vascular calcification［J］. Front Physiol， 2021， 12： 676727.
［19］ Goel S，Guo LW，Shi XD，et al. Preferential secretion of collagen type 3 versus type 1 from adventitial fibroblasts stimulated by TGF- β/Smad3- treated medial smooth muscle cells［J］. Cell Signal， 2013， 25： 955- 960.
［20］ Li G，Chen SJ，Oparil S，et al. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries［J］. Circulation， 2000， 101： 1362- 1365.
［21］ Cai WJ，Koltai S，Kocsis E，et al. Remodeling of the adventitia during coronary arteriogenesis［J］. Am J Physiol Heart Circ Physiol， 2003， 284： H31- H40.
［22］ Xu JY，Shi GP. Vascular wall extracellular matrix proteins and vascular diseases［J］. Biochim Biophys Acta Mol Basis Dis， 2014， 1842： 2106- 2119.
［23］ 陈闻东，楚玉峰，李晓东，等． 血管紧张素Ⅱ诱导血管外膜成纤维细胞表达炎症介质［J］． 生理学报， 2015， 67：603- 610．
［24］ Xing D，Miller A，Novak L，et al. Estradiol and progestins differen- tially modulate leukocyte infiltration after vascular injury［J］. Circulation， 2004， 109： 234- 241.
［25］ Fuentes QE， Fuentes QF，Andres V， et al. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis［J］. Platelets， 2013， 24： 255- 262.
［26］ 尹 晶，吴清华，王 鹏，等． 下肢动脉硬化闭塞症患者介入术后白细胞介素- 8，白细胞介素- 18，血管内皮细胞生长因子检测及意义［J］． 介入放射学杂志， 2021， 30：132- 135．
［27］ Okamoto E，Couse T，De Leon H，et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries［J］. Circulation， 2001， 104： 2228- 2235.
［28］ Ji J，Xu F，Li L，et al. Activation of adventitial fibroblasts in the early stage of the aortic transplant vasculopathy in rat［J］. Trans- plantation， 2010， 89： 945- 953.
［29］ Moos MP， John N， Grabner R， et al. The lamina adventitia is the major site of immune cell accumulation in standard chow- fed apolipoprotein E- deficient mice［J］. Arterioscler Thromb Vasc Biol， 2005， 25： 2386- 2391.
［30］ Csanyi G，Taylor WR，Pagano PJ. NOX and inflammation in the vascular adventitia［J］. Free Radic Biol Med， 2009， 47： 1254- 1266.
［31］ Cautivo KM，Steer CA，Molofsky AB. Immune outposts in the adventitia： one foot in sea and one on shore［J］. Curr Opin Immunol， 2020， 64： 34- 41.
［32］ Ma Z，Mao C，Jia Y，et al. Extracellular matrix dynamics in vascular remodeling［J］. Am J Physiol Cell Physiol， 2020， 319： C481- C499.
［33］ Myasoedova VA，Chistiakov DA，Grechko AV，et al. Matrix metal- loproteinases in pro- atherosclerotic arterial remodeling［J］. J Mol Cell Cardiol， 2018， 123： 159- 167.
［34］ Haurani MJ，Pagano PJ. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling： bellwether for vascular disease?［J］. Cardiovasc Res， 2007， 75： 679- 689.
［35］ Stenmark KR，Yeager ME，El Kasmi KC，et al. The adventitia： essential regulator of vascular wall structure and function［J］. Annu Rev Physiol， 2013， 75： 23- 47.
［36］ Inoue T，Croce K，Morooka T，et al. Vascular inflammation and repair implications for re- endothelialization， restenosis， and stent thrombosis［J］. JACC Cardiovasc Interv， 2011， 4： 1057- 1066.
［37］ Tinajero MG，Gotlieb A. Recent developments in vascular adventitial pathobiology： the dynamic adventitia as a complex regulator of vascular disease［J］. Am J Pathol， 2020， 190： 520- 534.
［38］ Hoglund VJ，Dong XR，Majesky MW. Neointima formation： a local affair［J］. Arterioscler Thromb Vasc Biol， 2010， 30： 1877- 1879.
［39］ Ozen G，Daci A，Norel X，et al. Human perivascular adipose tissue dysfunction as a cause of vascular disease： focus on vascular tone and wall remodeling［J］. Eur J Pharmacol， 2015， 766： 16- 24.
［40］ Chang L， Garcia- Barrio MT，Chen Y. Perivascular adipose tissue regulates vascular function by targeting vascular smooth muscle cells［J］. Arterioscler Thromb Vasc Biol， 2020， 40： 1094- 1109.
［41］ Zhang YY，Shi YN，Zhu N，et al. PVAT targets VSMCs to regulate vascular remodelling： angel or demon［J］. J Drug Target， 2021， 29： 467- 475.
［42］ Man AC，Li H，Xia N. The role of sirtuin1 in regulating endothelial function，arterial remodeling and vascular aging［J］. Front Physiol， 2019， 10： 1173.
［43］ Ang HY，Xiong GM，Chaw SY，et al. Adventitial injection delivery of nano- encapsulated sirolimus（Nanolimus） to injury- induced porcine femoral vessels to reduce luminal restenosis［J］. J Control Release， 2020， 319： 15- 24.
［44］ Razavi MK，Donohoe D，D’agostino RB Jr， et al. Adventitial drug delivery of dexamethasone to improve primary patency in the treatment of superficial femoral and popliteal artery disease： 12- month results from the DANCE clinical trial［J］. JACC Cardiovasc Interv， 2018， 11： 921- 931.
［45］ Karanian JW，Peregoy JA，Chiesa OA，et al. Efficiency of drug delivery to the coronary arteries in swine is dependent on the route of administration： assessment of luminal， intimal， and adventitial coronary artery and venous delivery methods［J］. J Vasc Interv Radiol， 2010， 21： 1555- 1564.